HOLLADAY, MARK W.,LIU, GANG,ROWBOTTOM, MARTIN W.,XU, SHIMIN,HADD, MICHAEL J.,HOCKER, MICHAEL D.
申请号：
MYPI 2014700887
公开号：
MY167575A
申请日:
2012.10.12
申请国别(地区):
MY
年份:
2018
代理人:
摘要：
Provided herein are heterocyclic compounds for treatment of CSFIR, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions. Figure 1.
